Interventional management of neuropathic pain: NeuPSIG recommendations

Robert H. Dworkin, Alec B. O'Connor, Joel Kent, Sean C. Mackey, Srinivasa N. Raja, Brett R. Stacey, Robert M. Levy, Miroslav Backonja, Ralf Baron, Henning Harke, John D. Loeser, Rolf Detlef Treede, Dennis C. Turk, Christopher D. Wells

Research output: Contribution to journalArticle

208 Citations (Scopus)

Abstract

Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinical trials, and existing guidelines for the interventional management of NP. Evidence is summarized and presented for neural blockade, spinal cord stimulation (SCS), intrathecal medication, and neurosurgical interventions in patients with the following peripheral and central NP conditions: herpes zoster and postherpetic neuralgia (PHN); painful diabetic and other peripheral neuropathies; spinal cord injury NP; central poststroke pain; radiculopathy and failed back surgery syndrome (FBSS); complex regional pain syndrome (CRPS); and trigeminal neuralgia and neuropathy. Due to the paucity of high-quality clinical trials, no strong recommendations can be made. Four weak recommendations based on the amount and consistency of evidence, including degree of efficacy and safety, are: 1) epidural injections for herpes zoster; 2) steroid injections for radiculopathy; 3) SCS for FBSS; and 4) SCS for CRPS type 1. Based on the available data, we recommend not to use sympathetic blocks for PHN nor radiofrequency lesions for radiculopathy. No other conclusive recommendations can be made due to the poor quality of available data. Whenever possible, these interventions should either be part of randomized clinical trials or documented in pain registries. Priorities for future research include randomized clinical trials, long-term studies, and head-to-head comparisons among different interventional and noninterventional treatments.

Original languageEnglish (US)
Pages (from-to)2249-2261
Number of pages13
JournalPain
Volume154
Issue number11
DOIs
StatePublished - Nov 2013

Fingerprint

Neuralgia
Spinal Cord Stimulation
Radiculopathy
Failed Back Surgery Syndrome
Postherpetic Neuralgia
Herpes Zoster
Trigeminal Nerve Diseases
Randomized Controlled Trials
Clinical Trials
Complex Regional Pain Syndromes
Epidural Injections
Reflex Sympathetic Dystrophy
Pain
Trigeminal Neuralgia
Public Opinion
Peripheral Nervous System Diseases
Spinal Cord Injuries
Registries
Steroids
Guidelines

Keywords

  • Clinical trials
  • Evidence-based recommendations
  • Intrathecal medication
  • Neural blockade
  • Neuropathic pain
  • Neurosurgery
  • Spinal cord stimulation

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine
  • Neurology
  • Pharmacology
  • Medicine(all)

Cite this

Dworkin, R. H., O'Connor, A. B., Kent, J., Mackey, S. C., Raja, S. N., Stacey, B. R., ... Wells, C. D. (2013). Interventional management of neuropathic pain: NeuPSIG recommendations. Pain, 154(11), 2249-2261. https://doi.org/10.1016/j.pain.2013.06.004

Interventional management of neuropathic pain : NeuPSIG recommendations. / Dworkin, Robert H.; O'Connor, Alec B.; Kent, Joel; Mackey, Sean C.; Raja, Srinivasa N.; Stacey, Brett R.; Levy, Robert M.; Backonja, Miroslav; Baron, Ralf; Harke, Henning; Loeser, John D.; Treede, Rolf Detlef; Turk, Dennis C.; Wells, Christopher D.

In: Pain, Vol. 154, No. 11, 11.2013, p. 2249-2261.

Research output: Contribution to journalArticle

Dworkin, RH, O'Connor, AB, Kent, J, Mackey, SC, Raja, SN, Stacey, BR, Levy, RM, Backonja, M, Baron, R, Harke, H, Loeser, JD, Treede, RD, Turk, DC & Wells, CD 2013, 'Interventional management of neuropathic pain: NeuPSIG recommendations', Pain, vol. 154, no. 11, pp. 2249-2261. https://doi.org/10.1016/j.pain.2013.06.004
Dworkin RH, O'Connor AB, Kent J, Mackey SC, Raja SN, Stacey BR et al. Interventional management of neuropathic pain: NeuPSIG recommendations. Pain. 2013 Nov;154(11):2249-2261. https://doi.org/10.1016/j.pain.2013.06.004
Dworkin, Robert H. ; O'Connor, Alec B. ; Kent, Joel ; Mackey, Sean C. ; Raja, Srinivasa N. ; Stacey, Brett R. ; Levy, Robert M. ; Backonja, Miroslav ; Baron, Ralf ; Harke, Henning ; Loeser, John D. ; Treede, Rolf Detlef ; Turk, Dennis C. ; Wells, Christopher D. / Interventional management of neuropathic pain : NeuPSIG recommendations. In: Pain. 2013 ; Vol. 154, No. 11. pp. 2249-2261.
@article{33a3c65838c14b11a426835bc67b1865,
title = "Interventional management of neuropathic pain: NeuPSIG recommendations",
abstract = "Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinical trials, and existing guidelines for the interventional management of NP. Evidence is summarized and presented for neural blockade, spinal cord stimulation (SCS), intrathecal medication, and neurosurgical interventions in patients with the following peripheral and central NP conditions: herpes zoster and postherpetic neuralgia (PHN); painful diabetic and other peripheral neuropathies; spinal cord injury NP; central poststroke pain; radiculopathy and failed back surgery syndrome (FBSS); complex regional pain syndrome (CRPS); and trigeminal neuralgia and neuropathy. Due to the paucity of high-quality clinical trials, no strong recommendations can be made. Four weak recommendations based on the amount and consistency of evidence, including degree of efficacy and safety, are: 1) epidural injections for herpes zoster; 2) steroid injections for radiculopathy; 3) SCS for FBSS; and 4) SCS for CRPS type 1. Based on the available data, we recommend not to use sympathetic blocks for PHN nor radiofrequency lesions for radiculopathy. No other conclusive recommendations can be made due to the poor quality of available data. Whenever possible, these interventions should either be part of randomized clinical trials or documented in pain registries. Priorities for future research include randomized clinical trials, long-term studies, and head-to-head comparisons among different interventional and noninterventional treatments.",
keywords = "Clinical trials, Evidence-based recommendations, Intrathecal medication, Neural blockade, Neuropathic pain, Neurosurgery, Spinal cord stimulation",
author = "Dworkin, {Robert H.} and O'Connor, {Alec B.} and Joel Kent and Mackey, {Sean C.} and Raja, {Srinivasa N.} and Stacey, {Brett R.} and Levy, {Robert M.} and Miroslav Backonja and Ralf Baron and Henning Harke and Loeser, {John D.} and Treede, {Rolf Detlef} and Turk, {Dennis C.} and Wells, {Christopher D.}",
year = "2013",
month = "11",
doi = "10.1016/j.pain.2013.06.004",
language = "English (US)",
volume = "154",
pages = "2249--2261",
journal = "Pain",
issn = "0304-3959",
publisher = "Elsevier",
number = "11",

}

TY - JOUR

T1 - Interventional management of neuropathic pain

T2 - NeuPSIG recommendations

AU - Dworkin, Robert H.

AU - O'Connor, Alec B.

AU - Kent, Joel

AU - Mackey, Sean C.

AU - Raja, Srinivasa N.

AU - Stacey, Brett R.

AU - Levy, Robert M.

AU - Backonja, Miroslav

AU - Baron, Ralf

AU - Harke, Henning

AU - Loeser, John D.

AU - Treede, Rolf Detlef

AU - Turk, Dennis C.

AU - Wells, Christopher D.

PY - 2013/11

Y1 - 2013/11

N2 - Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinical trials, and existing guidelines for the interventional management of NP. Evidence is summarized and presented for neural blockade, spinal cord stimulation (SCS), intrathecal medication, and neurosurgical interventions in patients with the following peripheral and central NP conditions: herpes zoster and postherpetic neuralgia (PHN); painful diabetic and other peripheral neuropathies; spinal cord injury NP; central poststroke pain; radiculopathy and failed back surgery syndrome (FBSS); complex regional pain syndrome (CRPS); and trigeminal neuralgia and neuropathy. Due to the paucity of high-quality clinical trials, no strong recommendations can be made. Four weak recommendations based on the amount and consistency of evidence, including degree of efficacy and safety, are: 1) epidural injections for herpes zoster; 2) steroid injections for radiculopathy; 3) SCS for FBSS; and 4) SCS for CRPS type 1. Based on the available data, we recommend not to use sympathetic blocks for PHN nor radiofrequency lesions for radiculopathy. No other conclusive recommendations can be made due to the poor quality of available data. Whenever possible, these interventions should either be part of randomized clinical trials or documented in pain registries. Priorities for future research include randomized clinical trials, long-term studies, and head-to-head comparisons among different interventional and noninterventional treatments.

AB - Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinical trials, and existing guidelines for the interventional management of NP. Evidence is summarized and presented for neural blockade, spinal cord stimulation (SCS), intrathecal medication, and neurosurgical interventions in patients with the following peripheral and central NP conditions: herpes zoster and postherpetic neuralgia (PHN); painful diabetic and other peripheral neuropathies; spinal cord injury NP; central poststroke pain; radiculopathy and failed back surgery syndrome (FBSS); complex regional pain syndrome (CRPS); and trigeminal neuralgia and neuropathy. Due to the paucity of high-quality clinical trials, no strong recommendations can be made. Four weak recommendations based on the amount and consistency of evidence, including degree of efficacy and safety, are: 1) epidural injections for herpes zoster; 2) steroid injections for radiculopathy; 3) SCS for FBSS; and 4) SCS for CRPS type 1. Based on the available data, we recommend not to use sympathetic blocks for PHN nor radiofrequency lesions for radiculopathy. No other conclusive recommendations can be made due to the poor quality of available data. Whenever possible, these interventions should either be part of randomized clinical trials or documented in pain registries. Priorities for future research include randomized clinical trials, long-term studies, and head-to-head comparisons among different interventional and noninterventional treatments.

KW - Clinical trials

KW - Evidence-based recommendations

KW - Intrathecal medication

KW - Neural blockade

KW - Neuropathic pain

KW - Neurosurgery

KW - Spinal cord stimulation

UR - http://www.scopus.com/inward/record.url?scp=84886307868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886307868&partnerID=8YFLogxK

U2 - 10.1016/j.pain.2013.06.004

DO - 10.1016/j.pain.2013.06.004

M3 - Article

C2 - 23748119

AN - SCOPUS:84886307868

VL - 154

SP - 2249

EP - 2261

JO - Pain

JF - Pain

SN - 0304-3959

IS - 11

ER -